- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Studies of excessive production of AmpC β-lactamases by induction of <i>Enterobacter cloacae</i>
-
- MURAYAMA Miku
- Department of Clinical Laboratory, Aizawa Hospital
-
- FURUNO Yoshimi
- Department of Central Clinical Laboratory, Iizuka Hospital
-
- SHIMOJI Noriaki
- Department of Clinical Laboratory, Urazoe General Hospital
-
- ITO Manami
- Department of Clinical Laboratory, Hitachi, Ltd. Hitachi General Hospital
-
- TADACHI Hanayo
- Department of Clinical Laboratory, Aizawa Hospital
-
- AKATSU Yoshibumi
- Department of Clinical Laboratory, Hitachi, Ltd. Hitachi General Hospital
-
- OTSUKA Yoshihito
- Department of Laboratory Medicine, Kameda Medical Center
Bibliographic Information
- Other Title
-
- <i>Enterobacter cloacae</i>の誘導によるAmpC型β-lactamase過剰産生の検討
Search this article
Description
AmpC genes are encoded on the chromosome of Enterobacter cloacae. Excessive production of AmpC β-lactamases is induced by an antimicrobial agent. We examined the excessive production of AmpC β-lactamases using the E. cloacae strain that had been isolated from a clinical specimen by two methods. Consequently, AmpC β-lactamases were detected in 3.7% of the strains by the Cica β test, which is a third-generation cephem antibiotics susceptibility test in which AmpC genes were induced by the disc diffusion method. Additionally, for induction, the cells were cultured in CAZ Sub-MIC liquid culture medium with shaking, and the results showed 80% positivity for the lactamases. It is considered that there is a possibility that strains excessively producing AmpC β-lactamases exist in vivo, even when AmpC β-lactamases are not detected by clinical isolation because it is considered that a newer method is closer to the in vivo environment in terms of conditions. Moreover, this result shows that it is very important in antibiotic therapy to follow the dosage regimen, because antibiotic therapy with insufficient dosage promotes the excessive production of AmpC β-lactamases, and the patient may acquire an intractable infectious disease.
Journal
-
- Japanese Journal of Medical Technology
-
Japanese Journal of Medical Technology 64 (1), 34-39, 2015
Japanese Association of Medical Technologists
- Tweet
Details 詳細情報について
-
- CRID
- 1390282680719059712
-
- NII Article ID
- 130005057085
-
- ISSN
- 21885346
- 09158669
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed